All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

TRT 'for her too': what the evidence says about testosterone in women

Gameday Men’s Health

TikTok creator

9.1K viewsWatch on TikTok→

Quick answer

Testosterone therapy in women has evidence-backed use for hypoactive sexual desire disorder in postmenopausal women at physiological transdermal doses, per the 2019 Global Consensus Statement. No FDA-approved testosterone formulation exists for women in the US, making all prescriptions off-label and requiring individualized clinical justification. Monitoring for virilization and cardiovascular risk is required, and dosing should target female physiological ranges, not male optimization protocols.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What's this video probably claiming?

Based on the caption 'It's for HER too' paired with TRT category tags and relationship-focused hashtags like #betterhusbands and #betterpartner, this video is almost certainly pitching testosterone therapy as a couples wellness upgrade. The framing suggests that women should consider testosterone, possibly alongside their male partners, to boost energy, libido, and relationship quality. That's not a wild extrapolation. It's a pattern that's spread fast on TikTok in 2023-2024, where TRT clinics market hormone therapy as a shared lifestyle choice rather than a treatment for a diagnosed condition. Expect claims about low testosterone being the hidden cause of female fatigue, low sex drive, or mood issues, packaged with the idea that optimizing hormones together strengthens relationships.

What does the science actually show?

There is actual evidence supporting testosterone therapy for specific women, specifically postmenopausal women with hypoactive sexual desire disorder (HSDD). The 2019 Global Consensus Position Statement on testosterone in women, published in the Journal of Clinical Endocrinology and Metabolism (Davison et al., 2019), concluded that transdermal testosterone at physiological doses improves sexual function in this population. The APHRODITE trial (Davis et al., 2008, NEJM) showed 300 mcg/day transdermal testosterone patches improved satisfying sexual events by roughly 74% compared to placebo over 52 weeks in surgically menopausal women. But, and this matters, the evidence for testosterone improving energy, mood, cognitive function, or body composition in women without HSDD is weak. A 2014 Cochrane review found no consistent benefit on mood or wellbeing outside of sexual function endpoints.

Where does the social media noise diverge from clinical reality?

Here's where the TikTok version of this story goes sideways. The clinical evidence supports testosterone for a narrow indication in women, at physiological doses, under monitoring. Social media reframes it as a general energy and vitality upgrade for any woman who feels tired. That's a meaningful gap. Women are not a smaller version of men for testosterone biology. Normal female total testosterone ranges from roughly 15-70 ng/dL, compared to 300-1000 ng/dL in men. Supraphysiological dosing in women causes virilization, acne, clitoral enlargement, and voice changes, some of which are irreversible. The 'couples wellness' framing is also a marketing construct, not a clinical framework. No published trial has evaluated testosterone therapy outcomes using relationship satisfaction as a primary endpoint. The hashtag #betterhusbands appearing in a female hormone post is a flag worth noting.

What should you actually know?

If you're a woman considering testosterone therapy, the conversation should start with a proper hormonal workup, not a TikTok video. Free testosterone, SHBG, and total testosterone should be measured in the early morning, as levels fluctuate significantly. The Endocrine Society's 2014 clinical practice guidelines explicitly state that testosterone should not be prescribed to women without a diagnosed deficiency or a clear clinical indication. No testosterone product is currently FDA-approved for use in women in the United States, which means any prescription is off-label, and compounded formulations carry additional quality variables. That doesn't mean it's never appropriate. It means the decision belongs in a clinical conversation with real lab data, not a social media recommendation dressed up in relationship hashtags.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 5 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT 'for her too': what the evidence says about testosterone in women, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TRT 'for her too': what the evidence says about testosterone in women is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone therapy in women has evidence-backed use for hypoactive sexual desire disorder in postmenopausal women at physiological transdermal doses, per the 2019 Global Consensus Statement.

FormBlends verdict

Testosterone therapy in women has evidence-backed use for hypoactive sexual desire disorder in postmenopausal women at physiological transdermal doses, per the 2019 Global Consensus Statement. No FDA-approved testosterone formulation exists for women in the US, making all prescriptions off-label and requiring individualized clinical justification. Monitoring for virilization and cardiovascular risk is required, and dosing should target female physiological ranges, not male optimization protocols.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone therapy in women has evidence-backed use for hypoactive sexual desire disorder in postmenopausal women at physiological transdermal doses, per the 2019 Global Consensus Statement. No FDA-approved testosterone formulation exists for women in the US, making all prescriptions off-label and requiring individualized clinical justification. Monitoring for virilization and cardiovascular risk is required, and dosing should target female physiological ranges, not male optimization protocols.
  • Testosterone therapy in women has the strongest evidence for hypoactive sexual desire disorder in postmenopausal women, not general fatigue or wellness optimization.
  • Normal female testosterone levels are roughly 15-70 ng/dL, far below male ranges, and supraphysiological dosing causes irreversible virilization in some women.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone therapy in women has the strongest evidence for hypoactive sexual desire disorder in postmenopausal women, not general fatigue or wellness optimization.
  • Normal female testosterone levels are roughly 15-70 ng/dL, far below male ranges, and supraphysiological dosing causes irreversible virilization in some women.
  • No testosterone product is currently FDA-approved for women in the US; all female testosterone prescriptions are off-label.
  • The APHRODITE trial showed 300 mcg/day transdermal testosterone improved sexual outcomes in surgically menopausal women, but this is a specific population and dose, not a general recommendation.
  • The Endocrine Society advises against prescribing testosterone to women without a diagnosed deficiency and a clear clinical indication.
  • Compounded testosterone formulations used in women carry additional quality and dosing consistency variables not present in standardized products.
  • Relationship-framed marketing of hormone therapy is not a clinical category and should not substitute for individualized hormonal workup and provider consultation.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Gameday Men’s Health · TikTok creator

9.1K views on this video

It’s for HER too #strongertogether❤️ #betterhusbands #betterpartner #energymatters #confidencematters

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Gameday Men’s Health, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.